Denali Therapeutics Receives $217,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b9e60612-4c06-4c72-abce-61144fe0dd48
Date
5/15/2015
Company Name
Denali Therapeutics
Mailing Address
Undisclosed San Francisco, CA 94107 USA
Company Description
Denali is founded on the collaboration of leading scientists, industry experts and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
Website
http://www.denalitherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$217,000,000
Transaction Round
Undisclosed
Proceeds Purposes
The company will use the funds to discover and develop effective medicines for Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor